Skip to main content

Advertisement

SpringerLink
Log in

Botulinum toxin drugs: brief history and outlook

  • Neurology and Preclinical Neurological Studies - Review Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

The global botulinum toxin (BT) market is currently undergoing rapid changes: this may be the time to review the history and the future of BT drug development. Since the early 1990s Botox® and Dysport® dominated the international BT market. Later, Myobloc®/NeuroBloc®, a liquid BT type B drug, came out, but failed. Xeomin® is the latest major BT drug. It features removal of complexing proteins and improved neurotoxin purity. Several new BT drugs are coming out of Korea, China and Russia. Scientific challenges for BT drug development include modification of BT’s duration of action, its transdermal transport and the design of BT hybrid drugs for specific target tissues. The increased competition will change the global BT market fundamentally and a re-organisation according to large indication groups, such as therapeutic and cosmetic applications, might occur.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC (2011) OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program. Headache 51:1358–1373

    Article  PubMed  Google Scholar 

  • Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17–21

    Article  CAS  PubMed  Google Scholar 

  • Dressler D (2013) Clinical applications of botulinum toxin. Curr Opin Microbiol 15:325–336

    Article  Google Scholar 

  • Dressler D, Adib Saberi F, Bigalke H (in press) Botulinum toxin therapy: reduction of injection site pain by pH-normalisation. J Neural Transm

  • Paracka L, Kollewe K, Dengler R, Dressler D (2015) Botulinum toxin therapy for hyperhidrosis: reduction of injection site pain by nitrous oxide/oxygen mixtures. J Neural Transm 122:1279–1282

    Article  CAS  PubMed  Google Scholar 

  • Scott AB (1980) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 17:21–25

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Movement Disorder Section, Department of Neurology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany

    D. Dressler

Authors
  1. D. Dressler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Dressler.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dressler, D. Botulinum toxin drugs: brief history and outlook. J Neural Transm 123, 277–279 (2016). https://doi.org/10.1007/s00702-015-1478-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-015-1478-1

Keywords

Search

Navigation